Related Experiment Video
Updated: Jul 14, 2026
12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Suppression of HIV replication using RNA interference against HIV-1 integrase
Tat San Lau1, Yonggang Li, Masanori Kameoka
1Department of Biochemistry, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China.
FEBS Letters
|June 27, 2007
Summary
RNA interference (RNAi) effectively silences human immunodeficiency virus type 1 (HIV-1) integrase gene expression. This gene silencing reduces HIV-1 particle production, offering a potential therapeutic strategy against HIV replication.
Area of Science:
- Virology
- Molecular Biology
- Gene Therapy
Background:
- RNA interference (RNAi) is a powerful gene silencing technique, particularly in virology.
- Small interfering RNA (siRNA) offers gene-specific suppression.
- Human immunodeficiency virus type 1 (HIV-1) integrase (IN) is a critical enzyme for viral replication.
Purpose of the Study:
- To investigate the efficacy of vector-mediated small hairpin RNA (shRNA) targeting HIV-1 integrase.
- To assess the potential of RNAi as a therapeutic strategy against HIV-1.
Main Methods:
- Expression of shRNA targeting HIV-1 integrase (IN) in HeLa cells.
- Evaluation of EGFP-tagged IN protein synthesis suppression.
- Assessment of HIV-1 particle production in 293T cells using IN shRNA.
Main Results:
- Vector-mediated shRNA efficiently suppressed EGFP-tagged IN protein synthesis in HeLa cells.
- IN shRNA significantly reduced HIV-1 particle production in 293T cells.
- The reduction in viral particles was comparable to the positive control (HIV-1 tat shRNA).
Conclusions:
- RNAi targeting HIV-1 integrase demonstrates therapeutic potential for inhibiting HIV replication.
- shRNA-mediated gene silencing is a viable approach to reduce HIV-1 production.
- This study supports the development of RNAi-based therapies for HIV-1 infection.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...